FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact

FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact

Submitted by admin on July 31, 2017 - 9:56pm
Source: 
Fierce Pharma
News Tags: 
FDA
Herceptin
biosimilars
Roche
Amgen
Teva Pharmaceutical
Allergan
Celltrion
Headline: 
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact